DEFA14A

Proxy Materials

Starling Oncology, Inc. Filed 2022-06-03 Acc 0001193125-22-166809

Documents 1

DEFA14A Proxy Materials , d355482ddefa14a.htm

Around this filing

2023-04-28 DEFA14A Proxy Materials
2022-06-03 EFFECT Notice of Effectiveness
2022-06-03 DEFA14A Proxy Materials
2022-06-03 DEF 14A Proxy Statement
2022-06-03 424B3 Prospectus

Link to a passage

External

SEC EDGAR (opens in new tab)